EVUZAMITIDE
Lumbar Spinal Stenosis
University of Tennessee Graduate School of Medicineprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Lumbar Spinal Stenosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pregabalin University of Rochester | Phase 4 | BB |
Benadryl University of Rochester | Phase 4 | BB |
Activematrix Baylor College of Medicine | Phase 4 | NR |
Same molecule, other indications
EVUZAMITIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →